EMCURE PHARMACEUTICALS
Back to Balance Sheet
|
EMCURE PHARMACEUTICALS Last 5 Year Sundry Debtors History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Sundry Debtors | ₹2,002 Cr | ₹1,859 Cr | ₹1,648 Cr | ₹1,309 Cr | ₹1,475 Cr |
What is the latest Sundry Debtors ratio of EMCURE PHARMACEUTICALS ?
| Year | Sundry Debtors |
|---|---|
| Mar2025 | ₹2,002 Cr |
| Mar2024 | ₹1,859 Cr |
| Mar2023 | ₹1,648 Cr |
| Mar2022 | ₹1,309 Cr |
| Mar2021 | ₹1,475 Cr |
How is Sundry Debtors of EMCURE PHARMACEUTICALS Trending?
| Years | Sundry Debtors | % Change | |
|---|---|---|---|
| Mar2025 | ₹2,002 Cr | 7.72 | |
| Mar2024 | ₹1,859 Cr | 12.77 | |
| Mar2023 | ₹1,648 Cr | 25.97 | |
| Mar2022 | ₹1,309 Cr | -11.31 | |
| Mar2021 | ₹1,475 Cr | - | |
Compare Sundry Debtors of peers of EMCURE PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| EMCURE PHARMACEUTICALS | ₹37,302.6 Cr | 4% | 7% | 39.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹467,870.0 Cr | -1.4% | 2.4% | 17.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹220,946.0 Cr | 12.2% | 23.1% | 21.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹190,907.0 Cr | 2.4% | 5.3% | 41.7% | Stock Analytics | |
| CIPLA | ₹118,674.0 Cr | 1.7% | 0.7% | -3.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,648.7 Cr | 3% | -14.9% | -10.2% | Stock Analytics | |
EMCURE PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| EMCURE PHARMACEUTICALS | 4% |
7% |
39.2% |
| SENSEX | 2.4% |
1.5% |
-4.3% |
You may also like the below Video Courses